Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-30 Purchase | 2024-01-31 4:12 pm | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 444,444 | $18 | $7,999,992 | 1,513,664 (Indirect) | View |
| 2023-05-04 Purchase | 2023-05-08 5:22 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,460,932 | $2.797 | $4,086,235 | 1,902,937 (Indirect) | View |
| 2023-04-28 Purchase | 2023-05-02 9:34 pm | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 1,405,168 | $2.6146 | $3,673,901 | 1,328,967 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Disposition | 2024-04-05 4:33 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 8,009,729 | $0 | 0 (Indirect) | View |
| 2024-01-30 Conversion | 2024-01-31 4:12 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 2,582,884 | $0 | 1,513,664 (Indirect) | View |
Ownership | 2024-01-25 8:40 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 0 | $0 | 2,582,884 (Indirect) | View |
| 2023-02-17 Option Award | 2023-02-23 2:16 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 550,000 | $0 | 4,593,629 (Indirect) | View |
Ownership | 2023-02-23 1:58 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | OrbiMed Capital GP VIII LLC OrbiMed Asia GP IV L.P. OrbiMed Advisors IV Ltd Director 10% Owner | 0 | $0 | 1,100,000 (Indirect) | View |